fosfolipaser

Phospholipases are a family of enzymes that hydrolyze phospholipids, a major component of cell membranes. They act on glycerophospholipids such as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, releasing fatty acids and head groups. Based on the site of cleavage and reaction type, phospholipases are commonly categorized into four major classes: A, B, C, and D.

Phospholipase A enzymes (PLA) cleave a fatty acid from the glycerol backbone: PLA1 removes at the sn-1 position and PLA2 at the sn-2 position. Phospholipase B can remove acyl groups at both positions. Phospholipase C (PLC) cleaves the phosphodiester bond to yield diacylglycerol (DAG) and a phosphorylated head group such as phosphocholine or inositol phosphates. Phospholipase D (PLD) cleaves the bond between phosphate and head group, producing phosphatidic acid and a free head group.

Enzymes in these families differ in localization and regulation. Secreted phospholipase A2 (sPLA2) is typically Ca2+-dependent and released extracellularly. Cytosolic PLA2 (cPLA2) and calcium-independent PLA2 (iPLA2) operate inside cells and contribute to membrane remodeling and signaling. PLC enzymes are activated by receptors and generate second messengers DAG and IP3; PLD is regulated by small GTPases and lipid signals.

Physiological roles include digestion of dietary phospholipids, remodeling of membranes, and signaling through lipid mediators. In signaling, PLC-mediated DAG and IP3 regulate kinase and calcium pathways; PLA2 action releases arachidonic acid for eicosanoids, while PLD-generated phosphatidic acid participates in trafficking and signaling.

Clinical and research relevance: dysregulation of phospholipases is linked to inflammation, neurodegenerative diseases, cardiovascular conditions, and cancer. Venom-derived PLA2 enzymes have cytotoxic effects. Researchers study phospholipases using inhibitors and genetic models to understand lipid signaling and explore therapeutic approaches.